Arrestin: A Potential Drug Target and Biomarker (P8292)

Target Name: Arrestin

NCBI ID: P8292

Arrestin

Other Name(s): None

Arrestin: A Potential Drug Target and Biomarker

Arrestin, a protein found in all living cells, plays a critical role in the regulation of cell growth, apoptosis, and signaling pathways. Mutations in the arrestin gene have been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders. The unique structure and function of arrestin make it an attractive drug target and a potential biomarker for a variety of diseases.

The arrestin gene is located on chromosome 1p36 and encodes a protein with 181 amino acid residues. The protein has a characteristic C-type zinc finger and a distinct N-terminal region that is rich in multiple domains, including a nucleotide-binding oligomerization domain (NBO), a zinc finger, and a carboxy-terminal domain.

The NBO domain is a common feature in proteins that interact with nucleotides. In the case of arrestin, the NBO domain is responsible for the protein's ability to bind to and regulate the activity of specific nucleotides. This domain has been shown to play a critical role in the regulation of cell growth and apoptosis, as well as in the control of gene expression.

The zinc finger domain is a structural element that consists of four conserved zinc ions that are often involved in protein-protein interactions. In arrestin, the zinc ions are involved in the regulation of DNA replication, cell growth, and apoptosis. The presence of multiple zinc ions in the same protein suggests that they may play different roles in these processes, potentially contributing to the protein's complexity and function.

The carboxy-terminal domain is the final frontier in the study of arrestin function. This domain is involved in the regulation of protein stability, localization, and interactions with other cellular components. The carboxy-terminal domain has been shown to play a critical role in the regulation of arrestin's stability and localization to the endoplasmic reticulum, a process that is critical for the protein's function in regulating cell apoptosis.

In conclusion, the arrestin gene is a promising drug target due to its unique structure and function. The NBO, zinc finger, and carboxy-terminal domains suggest that arrestin is involved in various cellular processes, including cell growth, apoptosis, and signaling pathways. The identification of potential drug targets and biomarkers for arrestin-related diseases could have a significant impact on our understanding of these conditions and the development of new treatments.

Protein Name: Arrestin (nonspecified Subtype)

The "Arrestin Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Arrestin comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets